<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Basic and Clinical Neuroscience Journal</title>
<title_fa>مجله علوم اعصاب پایه و بالینی</title_fa>
<short_title>BCN</short_title>
<subject>Medical Sciences</subject>
<web_url>http://bcn.iums.ac.ir</web_url>
<journal_hbi_system_id>137</journal_hbi_system_id>
<journal_hbi_system_user>journal137</journal_hbi_system_user>
<journal_id_issn>2008-126X</journal_id_issn>
<journal_id_issn_online>2228-7442</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.32598/bcn</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1399</year>
	<month>12</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2021</year>
	<month>3</month>
	<day>1</day>
</pubdate>
<volume>12</volume>
<number>2</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Mutant Profilin1 Aggregation in Amyotrophic Lateral Sclerosis: An in Vivo Biochemical Analysis</title>
	<subject_fa>Cellular and molecular Neuroscience</subject_fa>
	<subject>Cellular and molecular Neuroscience</subject>
	<content_type_fa>Original</content_type_fa>
	<content_type>Original</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;strong&gt;Introduction&lt;/strong&gt;: Profilin1 (PFN1) is a ubiquitously expressed protein known for its function as a regulator of actin polymerization and dynamics. A recent discovery linked mutant PFN1 to Amyotrophic Lateral Sclerosis (ALS), which is a fatal and progressive motor neuron disease. We have also demonstrated that Gly118Val mutation in PFN1 is a cause of ALS, and the formation of aggregates containing mutant PFN1 may be a mechanism for motor neuron death. Hence, we were interested in investigating the aggregation of PFN1 further and searching for co-aggregated proteins in our mouse model overexpressing mutant PFN1.&lt;br&gt;
&lt;strong&gt;Methods&lt;/strong&gt;: We investigated protein aggregation in several tissues of transgenic and no-transgenic mice using western blotting. To further understand the neurotoxicity of mutant PFN1, we conducted a pull-down assay using an insoluble fraction of spinal cord lysates from hPFN1G118V transgenic mice. For this assay, we expressed His6-tagged PFN1WT and PFN1G118V in E. coli and purified these proteins using the Ni-NTA column.&lt;br&gt;
&lt;strong&gt;Results&lt;/strong&gt;: In this study, we demonstrated that mutant PFN1 forms aggregate in the brain and spinal cord of hPFN1G118V mice, while WT-PFN1 remains soluble. Among these tissues, spinal cord lysates were found to have PFN1 bands at higher molecular weights recognized with anti-PFN1. Moreover, the pull-down assay using His6-PFN1G118V showed that Myelin Binding Protein (MBP) was present in the insoluble fraction.&lt;br&gt;
&lt;strong&gt;Conclusion&lt;/strong&gt;: Our analysis of PFN1 aggregation in vivo revealed further details of mutant PFN1 aggregation and its possible complex formation with other proteins, providing new insights into the ALS mechanism.</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Motor neuron disease, Mutant PFN1 aggregation, Spinal cord, Transgenic mutant PFN1 mice</keyword>
	<start_page>213</start_page>
	<end_page>222</end_page>
	<web_url>http://bcn.iums.ac.ir/browse.php?a_code=A-10-1631-1&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Mina</first_name>
	<middle_name></middle_name>
	<last_name>Nekouei</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>m_nekouei@sbu.ac.ir</email>
	<code>13700319475328460033961</code>
	<orcid>13700319475328460033961</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Phytochemistry, Medicinal Plants and Drugs Research Institute, Shahid Beheshti University, Tehran, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Atousa</first_name>
	<middle_name></middle_name>
	<last_name>Aliahmadi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>a_aliahmadi@sbu.ac.ir</email>
	<code>13700319475328460033962</code>
	<orcid>13700319475328460033962</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Biology, Medicinal Plants and Drugs Research Institute, Shahid Beheshti University, Tehran, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Mahmoud</first_name>
	<middle_name></middle_name>
	<last_name>Kiaei</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>mkiaei@umas.edu</email>
	<code>13700319475328460033963</code>
	<orcid>13700319475328460033963</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Pharmacology and Toxicology, Department of Neurology, Department of Geriatrics, University of Arkansas for Medical Sciences, Little Rock, USA.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Ali Reza</first_name>
	<middle_name></middle_name>
	<last_name>Ghassempour</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>a-ghassempour@sbu.ac.ir</email>
	<code>13700319475328460033964</code>
	<orcid>13700319475328460033964</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Department of Phytochemistry, Medicinal Plants and Drugs Research Institute, Shahid Beheshti University, Tehran, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
